BURT A. ADELMAN - 12 May 2022 Form 4 Insider Report for Verve Therapeutics, Inc. (VERV)

Role
Director
Signature
/s/ Andrew Ashe, Attorney-in-Fact for Burt Adelman
Issuer symbol
VERV
Transactions as of
12 May 2022
Net transactions value
+$121,526
Form type
4
Filing time
13 May 2022, 16:37:15 UTC
Previous filing
17 Mar 2022
Next filing
13 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VERV Common Stock Purchase $121,526 +10,000 +115% $12.15 18,700 12 May 2022 Burt A Adelman 2002 Trust F1
holding VERV Common Stock 409,626 12 May 2022 The Burt A. Adelman 2021 GRAT
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average purchase price for shares purchased in multiple transactions. Purchase prices ranged from $12.10 to $12.20 per share. Upon request of the staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.